Solvej Lippert

Solvej Lippert is a Senior Scientist at Novo Nordisk since April 2016, specializing in the development and validation of immunoassays for peptides, cell and gene therapy, and oligonucleotides within regulated bioanalysis, adhering to GLP and GCLP standards. Prior to this role, Solvej Lippert served as a Postdoc at Copenhagen Prostate Cancer Center from April 2014 to April 2016 and conducted research during a Ph.D. at Rigshospitalet from September 2009 to April 2014, focusing on prostate cancer and the role of C-type natriuretic peptide (CNP). Earlier experiences include a research assistant position at the Muscle Research Centre and a background in neuronal stem cell research related to Parkinson's disease. Solvej Lippert holds a Cand.Scient. degree in Biomedicine from the University of Southern Denmark, having completed studies there between 2000 and 2007. The academic journey began with an upper secondary school leaving examination from Duborg-Skolen in Flensborg.